Filing Details
- Accession Number:
- 0001127602-15-002688
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-26 10:29:58
- Reporting Period:
- 2015-01-23
- Filing Date:
- 2015-01-26
- Accepted Time:
- 2015-01-26 10:29:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1614529 | E Dwight Ellingwood | 3471 River Hills Drive Cincinnati OH 45244 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-23 | 1,980 | $17.74 | 2,980 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Prices range from $17.72 per share to $17.75 per share. The reporting person undertakes to provide full pricing information ifrequested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.